![Andreas Pahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Pahl
Vorstandsvorsitzender bei
Heidelberg Pharma Research GmbH
Profil
Andreas Pahl is currently Managing Director at Heidelberg Pharma Research GmbH since 2024.
Former positions include Chief Executive Officer at Heidelberg Pharma AG from 2024 to 2025, Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd., Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg, Professor at Technical University of Berlin, Chief Scientific Officer at Heidelberg Pharma AG, Head-Late Pharmacology at Nycomed GmbH, and Member of the Supervisory Board at Emergence Therapeutics AG.
Education includes undergraduate studies at Humboldt-Universität zu Berlin.
Aktive Positionen von Andreas Pahl
| Unternehmen | Position | Beginn |
|---|---|---|
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Vorstandsvorsitzender | 01.02.2024 |
Ehemalige bekannte Positionen von Andreas Pahl
| Unternehmen | Position | Ende |
|---|---|---|
| HEIDELBERG PHARMA AG | Vorstandsvorsitzender | 24.11.2025 |
Nycomed GmbH
 Nycomed GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Direktor/Vorstandsmitglied | - |
Friedrich-Alexander University of Erlangen-Nuremberg
 Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Andreas Pahl
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Berlin
 Technical University of Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Nycomed GmbH
Nycomed GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Health Technology |
Wählen Sie MarketScreener 
